
What smart money is saying about Arjo
2 funds in our archive have pitched Arjo — most recently Protean Funds in March 2025.
Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and prevention of pressure injuries and leg ulcers, prevention of deep vein thrombosis, treatment of edema, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, as well as clinical consulting, maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. The company was founded in 1957 and is headquartered in Malmö, Sweden.
Fund coverage · 2 theses
- Protean FundsMarch 2025
Arjo is a modestly valued, non-cyclical business with strong potential for improvement and a solid balance sheet, making it an attractive risk/reward investment.
Read the full thesis - Protean FundsMarch 2025
Arjo is a compelling investment opportunity with improved prospects following strategic changes and favorable conditions in the medtech sector.
Read the full thesis
Read every full thesis on Arjo
Unlock all 2 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→